Search research articles
Contact Us
Filters
Showing results (181-190 of 186) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 186 results.
European Urology Oncology
|
June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
Luca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Urologic Oncology
|
July 19, 2022
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
Wojciech Krajewski, Júlia Aumatell, José Daniel Subiela, et al.
World Journal of Urology
|
October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
Ugo G Falagario, Anna Lantz, Ivan Jambor, et al.
BJU International
|
June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study
Bernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.
Journal of Personalized Medicine
|
May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 186) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 186 results.
European Urology Oncology
|
June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
Luca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Urologic Oncology
|
July 19, 2022
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
Wojciech Krajewski, Júlia Aumatell, José Daniel Subiela, et al.
World Journal of Urology
|
October 3, 2023
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
Ugo G Falagario, Anna Lantz, Ivan Jambor, et al.
BJU International
|
June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study
Bernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.
Journal of Personalized Medicine
|
May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Page
of 19